Loading
Everything in development, the open problems and what is being done about them, the roadmaps, and what changed on this record.
What is in development for Adolescent and young adult cancers (ages 15 to 39), drawn from the whole corpus: 4 items. Drugs are grouped by the most advanced trial phase they have reached anywhere; approved treatments sit under standard of care. Technologies are the methods being tested for this cancer, trials are the studies recorded here, and ideas are proposals not yet in a trial.
Trial enrolment in AYA remains far below that of children.
Fertility preservation is offered unevenly and paid for inconsistently.
Why the same cancer behaves differently at different ages is largely unexplained.
Dated changes read from the records linked to this cancer: approvals, regulatory steps, reported trials, guideline versions and milestones. Newest first; no date is inferred.
On EdgeAll 9 changes by month →When this page itself was last checked or edited.
3-year OS 85% vs 68%; HR 0.
A milestone in how this cancer is treated.
A milestone in how this cancer is treated.
15-year all-cause mortality among five-year survivors fell from 12.
A milestone in how this cancer is treated.